Table 5.
Average and maximum durations of use of systemic therapy
| Ciclosporin | Azathioprine | Methotrexate | Mycophenolic acid | Oral corticosteroids | |||||
|---|---|---|---|---|---|---|---|---|---|
| n = 201 | n = 135 | n = 199 | n = 85 | n = 184 | |||||
| Average duration (months) | |||||||||
| Duration | n (%) | Duration | n (%) | Duration | n (%) | Duration | n (%) | Duration | n (%) |
| 0–3 | 21 (10·4) | 0–3 | 12 (8·9) | 0–3 | 13 (6·5) | 0–3 | 3 (4) | < 1 | 143 (77·7) |
| 4–6 | 86 (42·8) | 4–6 | 15 (11·1) | 4–6 | 25 (12·6) | 4–6 | 10 (12) | 1–3 | 36 (19·6) |
| 7–12 | 61 (30·3) | 7–12 | 43 (31·9) | 7–12 | 47 (23·6) | 7–12 | 31 (36) | 4–6 | 4 (2·2) |
| 13–18 | 21 (10·4) | 13–18 | 27 (20·0) | 13–18 | 36 (18·1) | 13–18 | 17 (20) | 7–12 | 1 (0·5) |
| 19–24 | 10 (5·0) | 19–24 | 22 (16·3) | 19–24 | 34 (17·1) | 19–24 | 11 (13) | 13–18 | 0 (0·0) |
| > 24 | 2 (1·0) | > 24 | 16 (11·9) | > 24 | 44 (22·1) | > 24 | 13 (15) | 19–24 | 0 (0·0) |
| > 24 | 0 (0·0) | ||||||||
| Maximum duration (months) | |||||||||
| Duration | n (%) | Duration | n (%) | Duration | n (%) | Duration | n (%) | Duration | n (%) |
| 0–3 | 3 (1·5) | 0–3 | 2 (1·5) | 0–3 | 3 (1·5) | 0–3 | 2 (2) | < 1 | 74 (40·2) |
| 4–6 | 27 (13·4) | 4–6 | 12 (8·9) | 4–6 | 14 (7·0) | 4–6 | 2 (2) | 1–3 | 80 (43·5) |
| 7–12 | 64 (31·8) | 7–12 | 17 (12·6) | 7–12 | 23 (11·6) | 7–12 | 13 (15) | 4–6 | 24 (13·0) |
| 13–18 | 25 (12·4) | 13–18 | 10 (7·4) | 13–18 | 16 (8·0) | 13–18 | 8 (9) | 7–12 | 3 (1·6) |
| 19–24 | 55 (27·4) | 19–24 | 27 (20·0) | 19–24 | 15 (7·5) | 19–24 | 13 (15) | 13–18 | 0 (0·0) |
| > 24 | 27 (13·4) | > 24 | 67 (49·6) | > 24 | 128 (64·3) | > 24 | 47 (55) | 19–24 | 1 (0·5) |
| > 24 | 2 (1·1) | ||||||||